Literature DB >> 10597258

Regulation of the Wilms' tumour suppressor protein transcriptional activation domain.

L M McKay1, B Carpenter, S G Roberts.   

Abstract

The Wilms' tumour suppressor protein WT1 contains a transcriptional regulatory domain that can either activate or repress transcription depending upon its cellular environment. The mechanistic basis for this dichotomy is unclear however. Here, we dissect the transcriptional regulatory domains of WT1. We find that a region within the domain of WT1 attributed to transcriptional repression is a potent suppressor of the activation domain at several promoters and in different cell types. In vitro transcription analysis suggests that the mechanism of suppression of the activation domain occurs at the level of transcription initiation. Furthermore we find that the WT1 suppression domain is able to inhibit a heterologous activation domain when fused in cis. Dissection of this domain resulted in the delineation of a 30 amino acid region that was sufficient to confer suppression of a transcriptional activation domain both in vivo and in vitro. Additionally, we find that the WT1 transcriptional activation domain interacts with the general transcription factor TFIIB and that this interaction is not affected by the suppression domain. Taken together, these studies suggest that the suppression domain of WT1 interacts with a cosuppressor protein to mediate inhibition of the WT1 transcriptional activation domain.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10597258     DOI: 10.1038/sj.onc.1203046

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  15 in total

1.  TopBP1 contains a transcriptional activation domain suppressed by two adjacent BRCT domains.

Authors:  Roni H G Wright; Edward S Dornan; Mary M Donaldson; Iain M Morgan
Journal:  Biochem J       Date:  2006-12-15       Impact factor: 3.857

Review 2.  TFIIB and the regulation of transcription by RNA polymerase II.

Authors:  Wensheng Deng; Stefan G E Roberts
Journal:  Chromosoma       Date:  2007-06-26       Impact factor: 4.316

3.  TFIIB recognition elements control the TFIIA-NC2 axis in transcriptional regulation.

Authors:  Wensheng Deng; Barbora Malecová; Thomas Oelgeschläger; Stefan G E Roberts
Journal:  Mol Cell Biol       Date:  2008-12-29       Impact factor: 4.272

4.  Par4 is a coactivator for a splice isoform-specific transcriptional activation domain in WT1.

Authors:  D J Richard; V Schumacher; B Royer-Pokora; S G Roberts
Journal:  Genes Dev       Date:  2001-02-01       Impact factor: 11.361

5.  Repression of transcription by WT1-BASP1 requires the myristoylation of BASP1 and the PIP2-dependent recruitment of histone deacetylase.

Authors:  Eneda Toska; Hayley A Campbell; Jayasha Shandilya; Sarah J Goodfellow; Paul Shore; Kathryn F Medler; Stefan G E Roberts
Journal:  Cell Rep       Date:  2012-08-30       Impact factor: 9.423

6.  HtrA2, taming the oncogenic activities of WT1.

Authors:  Jörg Hartkamp; Stefan G E Roberts
Journal:  Cell Cycle       Date:  2010-07-01       Impact factor: 4.534

7.  The Wilms' tumor suppressor protein WT1 is processed by the serine protease HtrA2/Omi.

Authors:  Jörg Hartkamp; Brian Carpenter; Stefan G E Roberts
Journal:  Mol Cell       Date:  2010-01-29       Impact factor: 17.970

8.  Phosphorylation of TFIIB links transcription initiation and termination.

Authors:  Yuming Wang; Jennifer A Fairley; Stefan G E Roberts
Journal:  Curr Biol       Date:  2010-03-11       Impact factor: 10.834

Review 9.  Glucose signaling in Saccharomyces cerevisiae.

Authors:  George M Santangelo
Journal:  Microbiol Mol Biol Rev       Date:  2006-03       Impact factor: 11.056

10.  BASP1 is a transcriptional cosuppressor for the Wilms' tumor suppressor protein WT1.

Authors:  Brian Carpenter; Kathryn J Hill; Marika Charalambous; Kate J Wagner; Diya Lahiri; Dominic I James; Jens S Andersen; Valérie Schumacher; Brigitte Royer-Pokora; Matthias Mann; Andrew Ward; Stefan G E Roberts
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.